|
BRWD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54159999998793E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.56999999995278E-06 |
| Normal-vs-Stage2 |
5.641400E-04 |
| Normal-vs-Stage3 |
1.89400000016882E-07 |
| Normal-vs-Stage4 |
3.340000E-03 |
| Stage1-vs-Stage2 |
7.054800E-01 |
| Stage1-vs-Stage3 |
6.046000E-02 |
| Stage1-vs-Stage4 |
6.757800E-01 |
| Stage2-vs-Stage3 |
3.566200E-01 |
| Stage2-vs-Stage4 |
9.014600E-01 |
| Stage3-vs-Stage4 |
5.594200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.87909999969239E-07 |
| Normal-vs-AfricanAmerican |
5.247200E-04 |
| Normal-vs-Asian |
2.642000E-03 |
| Caucasian-vs-AfricanAmerican |
5.165200E-01 |
| Caucasian-vs-Asian |
6.730400E-01 |
| AfricanAmerican-vs-Asian |
4.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13049999994619E-06 |
| Normal-vs-Female |
2.241100E-04 |
| Male-vs-Female |
4.956200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.200200E-04 |
| Normal-vs-Extreme_Weight |
1.73560000005235E-06 |
| Normal-vs-Obese |
5.003200E-04 |
| Normal-vs-Extreme_Obese |
3.154400E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.663600E-01 |
| Normal_Weight-vs-Obese |
7.602800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.802400E-01 |
| Extreme_Weight-vs-Obese |
2.554800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.259000E-01 |
| Obese-vs-Extreme_Obese |
2.182400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.428300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.602200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.92360000039749E-07 |
| Normal-vs-Age(81-100Yrs) |
1.159720E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.498400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.735600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.736800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.655600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.238800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.115000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.388100E-04 |
| Normal-VS-Type2 PRCC |
4.25140000981372E-09 |
| Normal-VS-KIRP CIMP |
7.046400E-04 |
| Normal-VS-Unclassified PRCC |
2.55660000003655E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.013100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.380600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.973500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.836400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.228600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.643200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.23760027068454E-10 |
| Normal-vs-N1 |
1.757780E-03 |
| Normal-vs-N2 |
7.843600E-03 |
| N0-vs-N1 |
1.918580E-01 |
| N0-vs-N2 |
9.599000E-01 |
| N1-vs-N2 |
5.558600E-01 |
|
|
